Background Hypertension has been associated with Alzheimer's disease (AD) dementia as
well as vascular dementia. However, the underlying neuropathological changes that link …

Introduction This study delineated the interrelationships among blood pressure (BP),
cerebrospinal fluid (CSF) core biomarkers of Alzheimer's disease (AD), and cognition …

Epidemiological evidence suggests that hypertension may accelerate the onset and
progression of Alzheimer′ s disease (AD). In this study, we explored the role of …

Background: Elevated blood pressure variability (BPV) is predictive of dementia,
independent of average blood pressure levels, but neuropathological mechanisms remain …

Vascular risk factors are implicated in the pathogenesis of Alzheimer's disease (AD). There
is an age-dependent relationship between blood pressure and the risk of AD. Given the …

Background: Recent observational studies suggest higher blood pressure (BP) variability
(BPV) is associated with Alzheimer's disease (AD) biomarkers amyloid-beta (Aβ) and tau …

Background We aimed to explore whether the relationships of blood pressures (BPs) with
Alzheimer's disease (AD) endophenotypes varied by usage of antihypertensive drugs …

β-Amyloid (Aβ), a vasoactive protein, and elevated blood pressure (BP) levels are
associated with Alzheimer disease (AD) and possibly vascular dementia. We investigated …

This study aimed to investigate the relationship of hypertension with beta-amyloid (Aβ) and
neurodegeneration biomarkers of Alzheimer's disease (AD) and the modulating effect of …

Abstract Alzheimer's disease (AD), the most common cause of dementia and the fifth leading
cause of death in the adult population has a complex pathophysiological link with …